Latest 5 articles from heartwire
- STS registry data on bypass surgery published for consumers
Sep 08, 2010 17:30 EDT - Evidence of stress in hair predicts AMI
Sep 08, 2010 16:00 EDT - UK experts advised rosiglitazone withdrawal in July
Sep 08, 2010 15:30 EDT - NSAID use associated with future stroke in healthy population
Sep 08, 2010 10:00 EDT - First Europe-specific guidance on AF
Sep 07, 2010 17:15 EDT
Internet resources that lead patients down the wrong path
Posted Sep 08, 2010
at 03:50 PM, EDT
by Seth Bilazarian
The objective of empowering patients with information that is pertinent to their condition is laudable, but in many cases patients become seriously misinformed by online resources, and much of an office visit can be spent trying to counter dangerously inappropriate information. Is this a trend that we can buck? Do you have a favorite online resource to which you refer your patients?
Previous postsBillets précédents
Apixaban in AVERROES points the way to excellent alternatives to warfarin
No commentsAucun commentaire |
Posted Aug 31, 2010
at 05:45 PM, EDT by Seth Publié le 08.31.2010 à 17h45 par Seth
at 05:45 PM, EDT by Seth Publié le 08.31.2010 à 17h45 par Seth
Four years on from the DES late-stent-thrombosis scare
No commentsAucun commentaire |
Posted Aug 25, 2010
at 09:20 AM, EDT by Seth Publié le 08.25.2010 à 09h20 par Seth
at 09:20 AM, EDT by Seth Publié le 08.25.2010 à 09h20 par Seth
Is defensive medicine all bad?
No commentsAucun commentaire |
Posted Aug 16, 2010
at 03:55 PM, EDT by Seth Publié le 08.16.2010 à 15h55 par Seth
at 03:55 PM, EDT by Seth Publié le 08.16.2010 à 15h55 par Seth
How do you tell an academic cardiologist from a private practitioner?
3 comments3 commentaires |
Posted Aug 06, 2010
at 09:30 AM, EDT by Seth Publié le 08.06.2010 à 09h30 par Seth
at 09:30 AM, EDT by Seth Publié le 08.06.2010 à 09h30 par Seth
When an EMR feels like a computer without internet how do we share health records?
1 comment1 commentaire |
Posted Jul 29, 2010
at 09:25 AM, EDT by Seth Publié le 07.29.2010 à 09h25 par Seth
at 09:25 AM, EDT by Seth Publié le 07.29.2010 à 09h25 par Seth
Also from theheart.org
About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:
- Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
- Practice approaches to the extra clinical issues in dealing with managed care insurers
- Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
- Experiences with restrictions on testing and imaging














